Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management
Caroline Piatek, MD
Irina Murakhovskaya, MD
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Gout Beyond the Joints: What’s the Hidden Danger?
What’s New About Gout? Rheumatology Perspective
Is Gout Hiding in the Nephrology Clinic?
Is Managing Gout in the Nephrology Clinic a Challenge?
What’s New About Gout? Nephrology Perspective
Should We Look for Gout in the Cardiology Clinic?
Can You Manage Patients With Uncontrolled Gout More Effectively?
What Are the Emerging Therapies for Managing Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
Mazen Noureddin, MD, MHSc
Assessing a Patient’s Willingness to Accept Treatment for AUD
Edwin A. Salsitz, MD, DFASAM
How, When, and Why to Conduct Brief AUD Interventions
Selecting an AUD Treatment: Off-Label Agents
Ethan A. Cowan, MD
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.